U.S. In Vitro Diagnostics Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. In Vitro Diagnostics Market 

5.1. COVID-19 Landscape: U.S. In Vitro Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global U.S. In Vitro Diagnostics Market, By Product

8.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Product, 2023-2032

8.1.1. Reagents

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Instruments

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Services

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global U.S. In Vitro Diagnostics Market, By Test Location

9.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Test Location, 2023-2032

9.1.1. Point of Care

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Home Care

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global U.S. In Vitro Diagnostics Market, By Technology 

10.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Technology, 2023-2032

10.1.1. Immunoassay

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Hematology

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Clinical Chemistry

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

10.1.4. Molecular Diagnostics

10.1.4.1. Market Revenue and Volume Forecast (2020-2032)

10.1.5. Coagulation

10.1.5.1. Market Revenue and Volume Forecast (2020-2032)

10.1.6. Microbiology

10.1.6.1. Market Revenue and Volume Forecast (2020-2032)

10.1.7. Others

10.1.7.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global U.S. In Vitro Diagnostics Market, By Application

11.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Application, 2023-2032

11.1.1. Diabetes

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Cardiology

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Nephrology

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

11.1.4. Infectious Disease

11.1.4.1. Market Revenue and Volume Forecast (2020-2032)

11.1.5. Oncology

11.1.5.1. Market Revenue and Volume Forecast (2020-2032)

11.1.6. Drug Testing

11.1.6.1. Market Revenue and Volume Forecast (2020-2032)

11.1.7. Autoimmune Diseases

11.1.7.1. Market Revenue and Volume Forecast (2020-2032)

11.1.8. Others

11.1.8.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global U.S. In Vitro Diagnostics Market, By End User

12.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by End User, 2023-2032

12.1.1. Standalone Laboratories

12.1.1.1. Market Revenue and Volume Forecast (2020-2032)

12.1.2. Hospitals

12.1.2.1. Market Revenue and Volume Forecast (2020-2032)

12.1.3. Academic & Medical Schools

12.1.3.1. Market Revenue and Volume Forecast (2020-2032)

12.1.4. Point-of-Care

12.1.4.1. Market Revenue and Volume Forecast (2020-2032)

12.1.5. Others

12.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 13. Global U.S. In Vitro Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.1.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.1.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.1.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.1.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.1.6.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.1.6.5. Market Revenue and Volume Forecast, by End User (2020-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.1.7.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.1.7.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.1.7.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.1.7.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.2.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.2.4. Market Revenue and Volume Forecast, by Application (2020-2032) 

13.2.5. Market Revenue and Volume Forecast, by End User (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.2.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.2.7. Market Revenue and Volume Forecast, by Application (2020-2032) 

13.2.8. Market Revenue and Volume Forecast, by End User (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.9.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.2.9.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.2.10. Market Revenue and Volume Forecast, by Application (2020-2032)

13.2.11. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.12.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.2.12.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.2.12.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.2.13. Market Revenue and Volume Forecast, by End User (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.2.14.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.2.14.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.2.14.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.2.15. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.3.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.3.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.3.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.3.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.3.6.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.3.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.8.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.3.8.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.3.8.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.3.9. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.10.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.3.10.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.3.10.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.3.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.3.11.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.3.11.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.3.11.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.3.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.4.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.4.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.4.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.4.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.4.6.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.4.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.8.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.4.8.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.4.8.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.4.9. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.10.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.4.10.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.4.10.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.4.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.4.11.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.4.11.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.4.11.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.4.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.5.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.5.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.5.5. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.6.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.5.6.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.5.6.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.5.7. Market Revenue and Volume Forecast, by End User (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

13.5.8.2. Market Revenue and Volume Forecast, by Test Location (2020-2032)

13.5.8.3. Market Revenue and Volume Forecast, by Technology (2020-2032)

13.5.8.4. Market Revenue and Volume Forecast, by Application (2020-2032)

13.5.8.5. Market Revenue and Volume Forecast, by End User (2020-2032)

Chapter 14. Company Profiles

14.1. Alere, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Beckman Coulter

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. BD

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Bio-Rad laboratories

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Danaher

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Abbott Laboratories

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Thermo Fisher Scientific Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. bioMérieux, Inc

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Quest Diagnostics

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Illumina, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms